← Back to the feed

Daysaver AG

History from 21 Aug 2020

UID

CHE-422.871.198

Legal form

AG

Canton

ZH

Founded

21 Aug 2020

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 26 Aug 2020 · legal date 21 Aug 2020

   Company formed

   Founded 21 Aug 2020

   SHAB HR01-1004964678 ↗

2. SHAB published 23 May 2022 · legal date 16 May 2022

   Converted to an AG

   GmbH → AG

   SHAB HR02-1005479437 ↗

3. SHAB published 23 May 2022 · legal date 16 May 2022

   Capital set in the conversion to an AG

   Not assessed

   Paid by converting claims

   Nominal capital

   25’000 → 100’000

   Shares

   — → 1’000’000

   New shares, % of post-step shares

   — (conversion to an AG)

   Umwandlung: Die Gesellschaft mit beschränkter Haftung hat das Stammkapital auf CHF 100'000.00 erhöht und wird gemäss Umwandlungsplan vom 16.05.2022 und Bilanz per 31.12.2021 mit Aktiven von CHF 113'456.20 und Passiven (Fremdkapital) von CHF 13'456.14 in eine Aktiengesellschaft umgewandelt. Rechtsform neu: Aktiengesellschaft. Aktienkapital neu: CHF 100'000.00 [bisher: CHF 25'000.00]. Liberierung Aktienkapital neu: CHF 100'000.00. Aktien neu: 1'000'000 Namenaktien zu CHF 0.10. Bei der Kapitalerhöhung vom 16.05.2022 wird frei verwendbares Eigenkapital in der Höhe von CHF 53'021.80 umgewandelt.

   SHAB HR02-1005479437 ↗

4. SHAB published 23 May 2022 · legal date 16 May 2022

   Name changed

   B-Men GmbH → Daysaver AG

   SHAB HR02-1005479437 ↗

5. SHAB published 28 Dec 2022 · legal date 21 Dec 2022

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   100’000 → 105’555.70

   Shares

   1’000’000 → 1’055’557

   New shares, % of post-step shares

   5.3% (55’557 new)

   Aktienkapital neu: CHF 105'555.70 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 105'555.70 [bisher: CHF 100'000.00]. Aktien neu: 1'055'557 Namenaktien zu CHF 0.10 [bisher: 1'000'000 Namenaktien zu CHF 0.10].

   SHAB HR02-1005639703 ↗

6. SHAB published 17 Jan 2025 · legal date 20 Dec 2024

   Capital increase

   Not assessed

   Paid in cash

   Nominal capital

   105’555.70 → 109’513.50

   Shares

   1’055’557 → 1’095’135

   New shares, % of post-step shares

   3.6% (39’578 new)

   Aktienkapital neu: CHF 109'513.50 [bisher: CHF 105'555.70]. Liberierung Aktienkapital neu: CHF 109'513.50 [bisher: CHF 105'555.70]. Aktien neu: 1'095'135 Namenaktien zu CHF 0.10 [bisher: 1'055'557 Namenaktien zu CHF 0.10].

   SHAB HR02-1006230713 ↗

7. SHAB published 5 Sep 2025 · legal date 29 Aug 2025

   Capital increase

   ●●○Likely financing

   Paid in cash

   Nominal capital

   109’513.50 → 117’109.50

   Shares

   1’095’135 → 1’171’095

   New shares, % of post-step shares

   6.5% (75’960 new)

   Aktienkapital neu: CHF 117'109.50 [bisher: CHF 109'513.50]. Liberierung Aktienkapital neu: CHF 117'109.50 [bisher: CHF 109'513.50]. Aktien neu: 1'171'095 Namenaktien zu CHF 0.10 [bisher: 1'095'135 Namenaktien zu CHF 0.10].

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.60 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006425634 ↗

8. SHAB published 15 Dec 2025 · legal date 4 Dec 2025

   Capital increase

   ○○○Capital increased

   Issued from conditional capital

   Nominal capital

   117’109.50 → 126’125.60

   Shares

   1’171’095 → 1’261’256

   New shares, % of post-step shares

   7.1% (90’161 new)

   Aktienkapital neu: CHF 126'125.60 [bisher: CHF 117'109.50]. Liberierung Aktienkapital neu: CHF 126'125.60 [bisher: CHF 117'109.50]. Aktien neu: 1'261'256 Namenaktien zu CHF 0.10 [bisher: 1'171'095 Namenaktien zu CHF 0.10].

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5
   • Shares issued out of conditional capital, as when options are exercised.−1.0

   Classifier score 0.12 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006512231 ↗

Published by 8 Oct 2026